Matinas Biopharma Holdings Inc (AMEX:MTNB) has a beta value of 1.68 and has seen 0.6 million shares traded in the recent trading session. The MTNB stock price is -456.25% off its 52-week high price of $0.89 and 25.0% above the 52-week low of $0.12. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.66 million shares traded. The 3-month trading volume is 819.74K shares.
Matinas Biopharma Holdings Inc (AMEX:MTNB) trade information
Sporting 5.87% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the MTNB stock price touched $0.16 or saw a rise of 4.59%. Year-to-date, Matinas Biopharma Holdings Inc shares have moved -24.10%, while the 5-day performance has seen it change 6.84%. Over the past 30 days, the shares of Matinas Biopharma Holdings Inc (AMEX:MTNB) have changed -12.01%. Short interest in the company has seen 1.37 million shares shorted with days to cover at 1.6.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Matinas Biopharma Holdings Inc (MTNB) estimates and forecasts
The company’s shares have lost -21.03% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 7.12% over the past 5 years.
MTNB Dividends
Matinas Biopharma Holdings Inc is expected to release its next earnings report 2024-Aug-14 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Matinas Biopharma Holdings Inc (AMEX:MTNB)’s Major holders
Insiders own 2.53% of the company shares, while shares held by institutions stand at 15.68% with a share float percentage of 16.09%. Investors are also buoyed by the number of investors in a company, with Matinas Biopharma Holdings Inc having a total of 51.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 9.32 million shares worth more than $2.53 million. As of 2024-03-31, VANGUARD GROUP INC held 4.2887% of shares outstanding.
The other major institutional holder is SARGENT INVESTMENT GROUP, LLC, with the holding of over 3.61 million shares as of 2024-03-31. The firm’s total holdings are worth over $0.98 million and represent 1.6618% of shares outstanding.
